Haleon Stock Price, News & Analysis (NYSE:HLN) $8.58 +0.02 (+0.23%) (As of 12/1/2023 ET) Add Compare Share Share Today's Range$8.49▼$8.6050-Day Range$7.78▼$8.6352-Week Range$7.01▼$9.05Volume4.77 million shsAverage Volume3.62 million shsMarket Capitalization$39.62 billionP/E RatioN/ADividend Yield1.05%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Haleon MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.44% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.74Based on 4 Articles This WeekInsider TradingN/AProj. Earnings Growth8.89%From $0.45 to $0.49 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.54 out of 5 starsMedical Sector878th out of 953 stocksToilet Preparations Industry12th out of 13 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Haleon. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.44% of the float of Haleon has been sold short.Short Interest Ratio / Days to CoverHaleon has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in Haleon has recently decreased by 3.42%, indicating that investor sentiment is improving. Previous Next 1.7 Dividend Strength Dividend YieldHaleon pays a meaningful dividend of 1.02%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthHaleon does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Haleon will have a dividend payout ratio of 18.37% next year. This indicates that Haleon will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HLN. Previous Next 2.1 News and Social Media Coverage News SentimentHaleon has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Haleon this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for HLN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Haleon to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Haleon insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 6.67% of the stock of Haleon is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Haleon are expected to grow by 8.89% in the coming year, from $0.45 to $0.49 per share.Price to Earnings Growth RatioHaleon has a PEG Ratio of 2.92. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHaleon has a P/B Ratio of 1.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Haleon Stock (NYSE:HLN)Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.Read More HLN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HLN Stock News HeadlinesDecember 3, 2023 | americanbankingnews.comHaleon (NYSE:HLN) Sees Strong Trading VolumeDecember 1, 2023 | benzinga.comLooking Into Haleon's Recent Short InterestDecember 3, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.November 28, 2023 | msn.com1 Pharma Stock to Buy on Strong Vaccine Growth PotentialNovember 26, 2023 | americanbankingnews.comCritical Analysis: Oddity Tech (NASDAQ:ODD) & Haleon (NYSE:HLN)November 23, 2023 | seekingalpha.comHaleon's Long-Term Growth Prospects Look Healthy On Solid Macro TrendsNovember 20, 2023 | seekingalpha.comHaleon: A Stable PickNovember 7, 2023 | msn.comThe Haleon share price is stuck at £3! Should I invest?December 3, 2023 | DTI Trader (Ad)All the trading advice you’ve ever received boils down to thisAll the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.November 2, 2023 | lse.co.ukTOP NEWS: Haleon maintains full-year guidance as profit edges upNovember 2, 2023 | nl.investing.comHALEON ADR winst en omzet lager dan voorspeldNovember 2, 2023 | msn.comAdvil maker Haleon's quarterly revenue rises on price hikes, strong demandOctober 20, 2023 | msn.comCVS pulling OTC cold medicines containing nasal decongestant phenylephrineOctober 20, 2023 | msn.comCVS Pulls Some Cold Medicines From Its Shelves. What It Means for Stocks.August 24, 2023 | finance.yahoo.comHaleon plc: Recent weakness provides buying opportunityAugust 2, 2023 | seekingalpha.comHaleon plc 2023 Q2 - Results - Earnings Call PresentationJuly 26, 2023 | reuters.comGSK raises 2023 outlook boosted by vaccine, HIV drug salesJuly 17, 2023 | finance.yahoo.comReturns Are Gaining Momentum At Haleon (LON:HLN)July 14, 2023 | proactiveinvestors.comHaleon reportedly plans sweeping jobs cutsJuly 12, 2023 | msn.comA Look Into Haleon Inc's Price Over EarningsJune 29, 2023 | seekingalpha.comHaleon: Leading Business In An Attractive IndustryJune 11, 2023 | seekingalpha.comHaleon: A Hidden Gem In The Consumer Health MarketJune 2, 2023 | finance.yahoo.comDoes The Market Have A Low Tolerance For Haleon plc's (LON:HLN) Mixed Fundamentals?May 24, 2023 | wsj.comHaleon PLCMay 12, 2023 | msn.comGSK cuts its Haelon stake in $1B share saleMay 5, 2023 | seekingalpha.comHaleon: Brand Portfolio Strength Keeps Us BullishApril 19, 2023 | proactiveinvestors.comHaleon profit margin may disappoint, says BarclaysSee More Headlines Receive HLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 10/5 Dividend8/24/2023Dividend Payable10/05/2023Last Earnings11/02/2023Today12/02/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/18/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Toilet preparations Sub-IndustryN/A SectorMedical Current SymbolNYSE:HLN CUSIPN/A CIK1900304 Webwww.haleon.com Phone44-19-3282-2000FaxN/AEmployees24,622Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio19.07 P/E Growth2.91Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.53 Current Ratio0.84 Quick Ratio0.54 Sales & Book Value Annual Sales$13.43 billion Price / Sales2.95 Cash Flow$0.36 per share Price / Cash Flow23.72 Book Value$4.41 per share Price / Book1.95Miscellaneous Outstanding Shares4,617,290,000Free FloatN/AMarket Cap$39.62 billion OptionableNot Optionable Beta0.33 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Brian McNamara (Age 56)CEO & Executive Director Comp: $2.93MMr. Tobias Hestler (Age 50)CFO & Executive Director Comp: $1.25MMs. Amy LanducciChief Digital & Technology OfficerMs. Sonya Ghobrial (Age 49)Head of Investor Relations Mr. Bjarne Philip Tellmann (Age 56)General Counsel Ms. Tamara Rogers (Age 53)Chief Marketing Officer Ms. Mairead Nayager (Age 48)Chief Human Resources Officer Mr. Bart Derde (Age 53)Chief Supply Chain Officer Mr. Filippo LanziPresident of EMEA & LatAmMs. Teri Lyng (Age 60)Head of Transformation & Sustainability More ExecutivesKey CompetitorsSeagenNASDAQ:SGENIDEXX LaboratoriesNASDAQ:IDXXCenteneNYSE:CNCEdwards LifesciencesNYSE:EWCencoraNYSE:CORView All CompetitorsInstitutional OwnershipWellington Management Group LLPBought 5,118,871 shares on 12/1/2023Ownership: 0.111%American Century Companies Inc.Bought 205,026 shares on 11/30/2023Ownership: 0.010%EP Wealth Advisors LLCBought 3,668 shares on 11/24/2023Ownership: 0.000%Deutsche Bank AGSold 5,832 shares on 11/24/2023Ownership: 0.000%Morgan StanleyBought 35,266 shares on 11/16/2023Ownership: 0.134%View All Institutional Transactions HLN Stock Analysis - Frequently Asked Questions Should I buy or sell Haleon stock right now? 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HLN shares. View HLN analyst ratings or view top-rated stocks. How have HLN shares performed in 2023? Haleon's stock was trading at $8.00 at the beginning of the year. Since then, HLN shares have increased by 7.3% and is now trading at $8.58. View the best growth stocks for 2023 here. Are investors shorting Haleon? Haleon saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 21,050,000 shares, a drop of 7.1% from the October 15th total of 22,660,000 shares. Based on an average trading volume of 5,310,000 shares, the days-to-cover ratio is currently 4.0 days. Approximately 0.5% of the shares of the stock are sold short. View Haleon's Short Interest. When is Haleon's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, March 18th 2024. View our HLN earnings forecast. How were Haleon's earnings last quarter? Haleon plc (NYSE:HLN) released its quarterly earnings results on Thursday, November, 2nd. The company reported $0.10 earnings per share for the quarter. The firm earned $3.54 billion during the quarter. How often does Haleon pay dividends? What is the dividend yield for Haleon? Haleon announced a -- dividend on Wednesday, August 2nd. Shareholders of record on Friday, August 25th will be paid a dividend of $0.046 per share on Thursday, October 5th. This represents a yield of 1.3%. The ex-dividend date is Thursday, August 24th. Read our dividend analysis for HLN. Is Haleon a good dividend stock? Haleon (NYSE:HLN) pays an annual dividend of $0.09 per share and currently has a dividend yield of 1.02%. Read our dividend analysis for HLN. What ETFs hold Haleon's stock? ETFs with the largest weight of Haleon (NYSE:HLN) stock in their portfolio include VanEck Pharmaceutical ETF (PPH), Pacer BioThreat Strategy ETF (VIRS), ClearBridge Focus Value ESG ETF (CFCV), Horizon Kinetics Medical ETF (MEDX), Who are Haleon's major shareholders? Haleon's stock is owned by many different retail and institutional investors. Top institutional investors include FMR LLC (1.17%), Clearbridge Investments LLC (0.56%), JTC Employer Solutions Trustee Ltd (0.20%), Douglas Lane & Associates LLC (0.17%), Morgan Stanley (0.13%) and Envestnet Asset Management Inc. (0.13%). How do I buy shares of Haleon? Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NYSE:HLN) was last updated on 12/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haleon plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.